Yuhan Company Description

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally.

It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support.

The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others.

Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Yuhan Corporation

Country	South Korea
Founded	1926
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,067
CEO	Wook-Je Cho

Contact Details

Address: 74, Noryangjin-ro Seoul South Korea
Phone	82 2 828 0181
Website	yuhan.co.kr

Stock Details

Ticker Symbol	000100
Exchange	Korea Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7000100008
SIC Code	2833

Key Executives

Name	Position
Wook-Je Cho	President, Chief Executive Officer and Executive Director
Yeul-Hong Kim	President, Research & Development Director and Executive Director
Byung-Man Lee	Vice President, Head of the Mngt. HQ. and Internal Accounting Manager
Joo-Yong Chung	MD and Head of Marketing Department
Jae-Kyo Kim	Vice President and Head of the Pharmaceutical Business Division
Sung-Soo Kim	MD and Head of the Lifestyle Health Business Division
Jun-Hwan Kim	MD and Head of Biopharmaceutical Division
Min Chul Cho	MD and ESG Management Director